Description
CJC-1295 without DAC, also known as Modified GRF (1-29), is a short-acting synthetic analog of growth hormone-releasing hormone lacking the drug affinity complex modification. It serves as a GHRH receptor agonist with a brief activity window.
Studies have focused on pituitary growth hormone release, GHRH receptor signaling, and pulsatile secretion patterns in cultured cells and rodents. Its rapid clearance makes it well suited to short-interval, time-resolved experimental designs.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.